UNRESECTABLE COLORECTAL ADENOCARCINOMA
Clinical trials for UNRESECTABLE COLORECTAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE COLORECTAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE COLORECTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to boost colorectal cancer treatment
Disease control Recruiting nowThis early-stage trial tests whether adding the experimental drug CA-4948 to standard chemotherapy (FOLFOX) and bevacizumab is safe and tolerable for people with colorectal cancer that has spread. About 24 adults with advanced, inoperable disease will receive the combination to f…
Matched conditions: UNRESECTABLE COLORECTAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 11, 2026 12:09 UTC
-
New hope for Tough-to-Treat colorectal cancer: drug combo trial launches
Disease control Recruiting nowThis study tests two drugs, pidnarulex and cemiplimab, in people with advanced colorectal cancer that hasn't responded to standard treatments. The goal is to find the best dose and see if the combination can slow or stop cancer growth. About 86 adults with a specific type of colo…
Matched conditions: UNRESECTABLE COLORECTAL ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 02, 2026 11:59 UTC